ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,949.17
      -0.60%
      US Tech 100
      20,194.80
      -0.75%
      Dow Jones
      43,750.86
      -0.47%
      Brent Oil
      71.705
      -0.70%
      Bitcoin
      89,289.79
      2.23%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Carisma Therapeutics Inc (CARM)

      7. Carisma Therapeutics Inc (CARM) News

      Carisma Therapeutics Inc

      Carisma Therapeutics Inc (CARM)

      Carmanah Minerals Corp
      Carrefour Property Development
      0.9389
      -0.0343
      (-3.52%)
      Closed November 14 4:00PM
      Delayed by 15 minutes
      0.9389
      0.00
      ( 0.00% )
      Pre Market: 4:07AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      CARM News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 07 2024
      CARM (-3.52%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 07 2024
      CARM (-3.52%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 01 2024
      CARM (-3.52%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      November 01 2024
      CARM (-3.52%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 30 2024
      CARM (-3.52%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 11 2024
      CARM (-3.52%)

      CARM Discussion

      View Posts
      PonkenPlonken PonkenPlonken 2 months ago
      I appreciate you reaching out. I like to follow the money in bioland or predict where it might go. Hence i really like this. Their CAR M CD47 approach is not new and many wished for these trials. The risk however is huge hence no one bit this (monotherapy trial with safety as primary endpoint is almost random)

      I am having a very close eye on this as they will share the first clinical data in q4. Any price increase prior might hint at things being right/a rally coming. The problem is, this is monotherapy only and not the one where they combine with the mRNA tech (which is likely where the good stuff is)

      So down the road we will be getting some great hints here on whether this might be "THE next big thing" or not.... A LOT of targets nominated by them...
      πŸ‘οΈ0
      jondoeuk jondoeuk 2 months ago
      From this: β€œWithout a doubt there's big biological risk here,” says Carisma CSO Michael Klichinsky. Researchers have yet to prove either the efficacy or the approvability of CAR macrophages. But solid tumours account for 90% of the cancer burden, making the possibility of activity in these settings with an in vivo reprogramming agent all the more appealing. β€œWe’re going after a real unmet need,” he adds. https://www.nature.com/articles/d41573-024-00150-z
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      Vdog, your dog stock shedding another 8.33% today on a pathetic 2 million shares. Going to trips withou a contract soon. Hope you get this message. You could be in Carisma if only you listened.
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      Vdog has no Carisma Therapeutics. Losers like him love losers like VXIT. Carisma up 50 % in 2 weeks, Vxit down 50%. LOVE to say I TOLD YOU SO! How's your DD treating you JA
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      Eat shi* vdog
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      Another 50,000 getting accumulated/ covered @ $1.04. To the moon, soon.
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      No noise here because Carisma is not a penny stock. This has moved nicely off of the bottom of .80 from last week. Plus 20%. Positive results from phase 2 study will solidify deal with Moderna and get this back up to levels seen mid June. Today's action, including buy, buy, buy of 75000 shares at 3:30 pm shows accumulation, or at least some worried shorts covering. Looking for strong move up on phase 2 results.
      πŸ‘οΈ0
      Prestotic Prestotic 3 months ago
      No noise here because Carisma in not a penny stock. This has moved nicely off of the bottom of .80 from last week. Plus 20%. Positive results from phase 2 study will solidify deal with Moderna and get this back up to levels seen mid July. Today's action, including buy, buy, buy of 75000 shares around 2pm shows accumulation, or at least something worried shorts covering. Looking for strong move up on phase 2 results.
      πŸ‘οΈ0
      CancunCharlie CancunCharlie 3 months ago
      Is there anyone here?? No comments in over a month. I think this looks good, but I'm wondering why it's so quite here.
      πŸ‘οΈ0
      PonkenPlonken PonkenPlonken 4 months ago
      pretty strong
      nice tech$
      πŸ‘οΈ0
      glenn1919 glenn1919 5 months ago
      CARM.......................https://stockcharts.com/h-sc/ui?s=CARM&p=W&b=5&g=0&id=p86431144783
      πŸ‘οΈ0
      Awl416 Awl416 5 months ago
      Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
      πŸ‘οΈ0
      Termite7 Termite7 6 months ago
      Could it be CARM under $0.30 ....???.......Thanks!!!
      πŸ‘οΈ0
      axelvento axelvento 6 months ago
      $1.46 bouncer
      πŸ‘οΈ0
      PonkenPlonken PonkenPlonken 7 months ago
      https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-023-00537-x
      MRNA provides the tech, 3bln + in biobucks and has not so distant private relative with TOP tier c suite.
      πŸ‘οΈ0
      Monksdream Monksdream 8 months ago
      CARM under $3
      πŸ‘οΈ0
      mrplmer mrplmer 11 months ago
      Whatever happened with their acquisition of Sesn Bio and their Bladder Cancer
      πŸ‘οΈ0
      mrplmer mrplmer 11 months ago
      Whatever happened with their acquisition of Sesn Bio and their Bladder Cancer
      πŸ‘οΈ0
      81vette 81vette 11 months ago
      1st higher high today and bid growing now,I got some 2.64,will see if dump continues or not
      πŸ‘οΈ0
      81vette 81vette 11 months ago
      Yea,distribution only so far today,I am watching for accumulation to start after this dumpathon,short interest went up 300% today also, 100k now,no sign of institutional buying yet,they currently hold 19%
      πŸ‘οΈ0
      stock1ace1 stock1ace1 11 months ago
      Red on news .. we no what that means lol
      πŸ‘οΈ0
      81vette 81vette 11 months ago
      Deal with Moderna for cancer cures,institutional might buy now lol,went up last time on this news,analysts target $9.50,short 2.45M,not optionable is good,gap filled down now,52 week low 2 weeks ago
      πŸ‘οΈ0

      Your Recent History

      NASDAQ
      CARM
      Carisma Therapeutics
      BOV
      PRNR3
      PRINER ON
      NASDAQ
      NCMI
      National CineMedia
      BIT
      UC3T3S
      Unicredit Bank
      TG
      HFG
      HelloFresh
      NASDAQ
      GOEV
      Canoo
      COIN
      ARBUSD
      Arbitrum
      Delayed Upgrade Clock